Brian Flatley

Papers

Total Citations

H-Index

About

Brian Flatley’s research sits at the intersection of cancer biology and advanced analytical chemistry, with a primary focus on prostate cancer biomarker discovery. His most cited work, "MALDI mass spectrometry in prostate cancer biomarker discovery" (2013), has garnered 48 citations and exemplifies his commitment to developing high-throughput, precise methods for identifying molecular signatures of disease. Flatley’s major contribution lies in applying matrix-assisted laser desorption/ionization (MALDI) mass spectrometry to clinical samples, enabling the detection of protein and peptide biomarkers that could improve early diagnosis, prognosis, and treatment monitoring for prostate cancer patients. His work bridges the gap between cutting-edge proteomic technology and practical oncology, offering a non-invasive window into tumor biology. While his citation count reflects a focused, emerging impact, Flatley’s research is notable for its methodological rigor and translational potential—paving the way for more personalized cancer care. For students and researchers, his profile demonstrates how specialized analytical tools can be harnessed to solve pressing clinical problems, making him a key figure to watch in the evolving landscape of cancer biomarker research.